74 filings
Page 3 of 4
S-8
cphry4
29 Mar 22
Registration of securities for employees
4:56pm
10-K
xowj5d
29 Mar 22
Annual report
4:20pm
8-K
lw4dqfohll7d1k9y
29 Mar 22
Lyell Immunopharma Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
4:15pm
8-K
hvfumx
15 Feb 22
Departure of Directors or Certain Officers
4:47pm
8-K
5niot9ek6xszy4
17 Dec 21
Lyell Immunopharma Announces cGMP Qualification of LyFE™ Manufacturing Center in Advance of Initiating Clinical Programs
4:02pm
8-K
dyocs7fa1j9lu3ov
3 Dec 21
Other Events
12:00am
8-K
xu9t50x
12 Nov 21
Lyell Immunopharma Reports Third Quarter 2021 Financial Results and Business Highlights
8:20am
8-K
z8pehg8
28 Oct 21
Departure of Directors or Certain Officers
12:00am
8-K/A
y9sg xcb6sl
1 Oct 21
Departure of Directors or Certain Officers
6:31am
8-K
gighctc0l854n y4d3
30 Sep 21
Departure of Directors or Certain Officers
4:05pm
10-Q
ex7o5 ts4p8
12 Aug 21
Quarterly report
5:07pm
8-K
ailqcjcb
12 Aug 21
Lyell Immunopharma Reports Second Quarter 2021 Financial Results and Business Highlights
4:18pm
S-8
o9vu1mae0ac7qozd
21 Jun 21
Registration of securities for employees
5:08pm
424B4
7we1 jwc0eqgn5
18 Jun 21
Prospectus supplement with pricing info
12:00am
EFFECT
nfxrybqn
17 Jun 21
Notice of effectiveness
12:15am
CERT
hdk1o2br1z93gd9gs7
16 Jun 21
Certification of approval for exchange listing
11:42am
SEC STAFF
uk19b7by
16 Jun 21
SEC staff action: Order
12:00am
8-A12B
fmc862z4bd
14 Jun 21
Registration of securities on exchange
4:56pm
CORRESP
grezyc7y 90u2ow
14 Jun 21
Correspondence with SEC
12:00am